Zurcher Kantonalbank (Zurich Cantonalbank) Roivant Sciences Ltd. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$33.8 Billion
Q1 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 102,478 shares of ROIV stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,478

Previous 93,121 10.05%

Holding current value

$1.14 Million

Previous $1.1 Million 6.09%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$10.09 - $12.08 $94,412 - $113,032	9,357 Added 10.05%	102,478 $1.03 Million
Q4 2024 Feb 07, 2025	BUY	$11.16 - $12.71 $154,387 - $175,830	13,834 Added 17.45%	93,121 $1.1 Million
Q2 2024 Jul 29, 2024	BUY	$10.36 - $11.74 $178,689 - $202,491	17,248 Added 27.8%	79,287 $838,000
Q1 2024 Apr 25, 2024	SELL	$9.87 - $11.8 $16,749 - $20,024	-1,697 Reduced 2.66%	62,039 $653,000
Q4 2023 Jan 30, 2024	SELL	$8.38 - $11.58 $35,891 - $49,597	-4,283 Reduced 6.3%	63,736 $715,000
Q3 2023 Oct 25, 2023	BUY	$9.76 - $13.19 $53,338 - $72,083	5,465 Added 8.74%	68,019 $794,000
Q2 2023 Aug 07, 2023	BUY	$7.09 - $10.08 $127,010 - $180,573	17,914 Added 40.13%	62,554 $630,000
Q1 2023 May 08, 2023	BUY	$6.92 - $9.98 $27,749 - $40,019	4,010 Added 9.87%	44,640 $329,000
Q4 2022 Feb 01, 2023	BUY	$3.36 - $7.99 $27,982 - $66,540	8,328 Added 25.78%	40,630 $324,000
Q2 2022 Aug 09, 2022	BUY	$2.81 - $4.84 $90,768 - $156,341	32,302 New	32,302 $131,000

Others Institutions Holding ROIV

# of Institutions

332

Shares Held

496M

Call Options Held

3.67M

Put Options Held

754K

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $7.8B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Roivant Sciences Ltd. Transaction History